CXCL14 and prostate cancer: For example, restored CXCL14 expression in HPV-positive oropharyngeal carcinoma is associated with better survival in immunocompetent syngeneic mice [72] but CXCL14-producing CAFs promoted tumor growth in a prostate cancer model [73].